Related Experiment Video
Updated: Nov 12, 2025

Co-staining Blood Vessels and Nerve Fibers in Adipose Tissue
Published on: February 13, 2019
The Interplay Between Adipose Tissue and Vasculature: Role of Oxidative Stress in Obesity
Yawen Zhou1, Huige Li1, Ning Xia1
1Department of Pharmacology, Johannes Gutenberg University Medical Center, Mainz, Germany.
Insights
Obesity causes oxidative stress in adipose tissue, impacting cardiovascular health. This review explores how this stress affects blood vessels and highlights potential therapeutic targets.
Area of Science:
- Biomedical Science
- Cardiovascular Research
- Metabolic Syndrome Studies
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of death.
- Obesity and metabolic syndrome are significant risk factors for CVDs.
- Oxidative stress is a common factor in both obesity and CVDs.
Purpose of the Study:
- To review the link between obesity-induced oxidative stress and vascular endothelial dysfunction.
- To explore the role of adipose tissue oxidative stress in cardiovascular health.
- To summarize adipocytokine-mediated crosstalk between adipose tissue and vasculature.
Main Methods:
- Literature review of studies on obesity, oxidative stress, adipose tissue, and cardiovascular function.
- Analysis of the pathophysiological mechanisms involved.
- Synthesis of current understanding on adipocytokine signaling.
Main Results:
- Obesity leads to oxidative stress in adipose tissues, impairing their function.
- Adipose tissue dysfunction and oxidative stress contribute to vascular endothelial dysfunction.
- Adipocytokines play a crucial role in the communication between adipose tissue and vasculature.
Conclusions:
- Oxidative stress in adipose tissue is a critical factor in obesity-related cardiovascular complications.
- Targeting adipose tissue oxidative stress may offer novel therapeutic strategies for CVDs.
- Further research into adipocytokine pathways is warranted for cardiovascular health.
Abstract:
Cardiovascular diseases (CVDs) rank the leading cause of morbidity and mortality globally. Obesity and its related metabolic syndrome are well-established risk factors for CVDs. Therefore, understanding the pathophysiological role of adipose tissues is of great importance in maintaining cardiovascular health. Oxidative stress, characterized by excessive formation of reactive oxygen species, is a common cellular stress shared by obesity and CVDs. While plenty of literatures have illustrated the vascular oxidative stress, very few have discussed the impact of oxidative stress in adipose tissues. Adipose tissues can communicate with vascular systems, in an endocrine and paracrine manner, through secreting several adipocytokines, which is largely dysregulated in obesity. The aim of this review is to summarize current understanding of the relationship between oxidative stress in obesity and vascular endothelial dysfunction. In this review, we briefly describe the possible causes of oxidative stress in obesity, and the impact of obesity-induced oxidative stress on adipose tissue function. We also summarize the crosstalk between adipose tissue and vasculature mediated by adipocytokines in vascular oxidative stress. In addition, we highlight the potential target mediating adipose tissue oxidative stress.
More Related Videos
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
06:56Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue
Published on: July 21, 2023
Related Concept Videos
Obesity
Hypodermis
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease I: Introduction
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion